Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.
作者信息
Elshaer Sally L, Lorys Renee E, El-Remessy A B
机构信息
Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia 30912, USA.
出版信息
Obes Control Ther. 2016;3(1). doi: 10.15226/2374-8354/3/1/00121. Epub 2016 Sep 15.
Abstract
摘要
相似文献
1
Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.
Obes Control Ther. 2016;3(1). doi: 10.15226/2374-8354/3/1/00121. Epub 2016 Sep 15.
2
Arginine pretreatment enhances circulating endothelial progenitor cell population and attenuates inflammatory response in high-fat diet-induced obese mice with limb ischemia.
Nutr Res. 2018 May;53:67-76. doi: 10.1016/j.nutres.2018.03.010. Epub 2018 Mar 23.
3
Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.
Cytotherapy. 2017 Feb;19(2):299-310. doi: 10.1016/j.jcyt.2016.10.013. Epub 2016 Nov 30.
4
[Cell therapy of critical lower limb ischemia (problems and prospects)].
Vestn Ross Akad Med Nauk. 2013(3):33-44. doi: 10.15690/vramn.v68i3.598.
5
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
Ann Surg. 2008 Mar;247(3):411-20. doi: 10.1097/SLA.0b013e318153fdcb.
6
Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia.
Stem Cell Res Ther. 2017 Jul 12;8(1):165. doi: 10.1186/s13287-017-0622-2.
7
Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.
Can J Physiol Pharmacol. 2017 Oct;95(10):1125-1140. doi: 10.1139/cjpp-2016-0713. Epub 2017 Apr 13.
8
Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
Exp Clin Transplant. 2011 Jun;9(3):197-202.
9
Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia.
J Cardiovasc Pharmacol Ther. 2020 Mar;25(2):158-163. doi: 10.1177/1074248419877411. Epub 2019 Sep 24.
10
An injectable elastin-based gene delivery platform for dose-dependent modulation of angiogenesis and inflammation for critical limb ischemia.
Biomaterials. 2015 Oct;65:126-39. doi: 10.1016/j.biomaterials.2015.06.037. Epub 2015 Jun 26.
引用本文的文献
1
miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia.
Mol Ther. 2018 Jul 5;26(7):1694-1705. doi: 10.1016/j.ymthe.2018.06.003. Epub 2018 Jun 15.
2
Deletion of TXNIP Mitigates High-Fat Diet-Impaired Angiogenesis and Prevents Inflammation in a Mouse Model of Critical Limb Ischemia.
Antioxidants (Basel). 2017 Jun 29;6(3):47. doi: 10.3390/antiox6030047.
本文引用的文献
1
Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.
Stem Cell Res Ther. 2015 Oct 7;6:179. doi: 10.1186/s13287-015-0178-y.
2
p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia.
Nat Commun. 2015 Aug 13;6:8024. doi: 10.1038/ncomms9024.
3
Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
Circ Res. 2015 Apr 24;116(9):1561-78. doi: 10.1161/CIRCRESAHA.115.303565.
4
The potential and challenges of using stem cells for cardiovascular repair and regeneration.
Genes Dis. 2014 Sep 1;1(1):113-119. doi: 10.1016/j.gendis.2014.07.003.
5
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
Obes Rev. 2015 Jan;16(1):1-12. doi: 10.1111/obr.12229. Epub 2014 Nov 18.
6
Hind limb ischemia-reperfusion injury in diet-induced obese mice.
J Surg Res. 2014 Aug;190(2):683-91. doi: 10.1016/j.jss.2014.01.020. Epub 2014 Jan 17.
7
Prevalence of childhood and adult obesity in the United States, 2011-2012.
JAMA. 2014 Feb 26;311(8):806-14. doi: 10.1001/jama.2014.732.
8
The current state of stem cell therapy for peripheral artery disease.
Curr Cardiol Rep. 2014 Feb;16(2):447. doi: 10.1007/s11886-013-0447-2.
9
Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
Biol Blood Marrow Transplant. 2014 Feb;20(2):236-42. doi: 10.1016/j.bbmt.2013.11.002. Epub 2013 Nov 8.
10
Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.
Regen Med. 2013 May;8(3):283-93. doi: 10.2217/rme.13.17.
Zotero 插件